Managers

Twentyeight-Seven Therapeutics grabs $65 mln Series A

Cambridge, Massachusetts-based Twentyeight-Seven Therapeutics, a biotech firm focused on modulating non-coding RNA biology to develop treatments for cancer and other diseases, has closed $65 million in Series A financing. MPM Capital and Novartis Venture Fund led the round with participation from other investors that included Johnson & Johnson Innovation – JJDC, Inc., Vertex Ventures HC, Longwood Fund and Astellas Venture Management.

Chinese entrepreneurs ahead in AI implementation, says investor Kai-Fu Lee

Cricket Health nabs $24 mln Series A

San Francisco-based Cricket Health, a provider of integrated kidney care, has secured $24 million in Series A funding. Oak HC/FT led the round with participation from other investors that included Cigna Corporation, LifeForce Capital, iSeed Ventures, Liquid 2 Ventures, First Round Capital, Box Group, Nexus Ventures, Seven Peaks Ventures, Aberdare Management and LinkedIn CEO Jeff Weiner.

Finnish women's health-focused drug developer Forendo Pharma lands funding

Forendo Pharma, a Finnish drug developer focusing on new treatments in women's health, has raised 4 million euros in funding. The investor was Vesalius Biocapital III Partners.

Alpha Tau Medical grabs $29 mln

Tel Aviv and Boston-based Alpha Tau Medical, a developer of alpha radiation cancer therapy, has secured $29 million in financing. Shavit Capital led the round with participation from other investors that included OurCrowd.com, Medison Ventures and the venture capital arm of Medison Pharma.

Westlake Village BioPartners gathers $320 mln for maiden fund

Los Angeles-based Westlake Village BioPartners, a venture firm focused on life sciences, has raised $320 million for its debut fund. Dr. Beth Seidenberg, a general partner at Kleiner Perkins and former chief medical officer and head of global development at Amgen and Dr. Sean Harper, executive vice president and head of R&D at Amgen, will lead Westlake’s investing activities. And, Scott Ryles, chief operating officer at Kleiner Perkins, will be Westlake's chief operating officer.

Four keys to successfully launching an ICO

Three former Social Capital partners form Tribe Capital

Brand Foundry Ventures to raise $150 mln for two funds

Brand Foundry Ventures has set out to raise for two funds, according to filings with the SEC.

Exor Seeds raises $75 mln venture-capital fund

Exor Seeds has raised a $75 million venture-capital fund, according to a filing with the SEC.